IP Library Granted Patent US 8,518,437
Granted Patent B2
US 8,518,437 · App. 10/294,474 · Granted Aug 27, 2013

Lipid carrier compositions with enhanced blood stability

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,518,437
App. No.
10/294,474
Granted
Aug 27, 2013
Kind
B2
Abstract

Liposomes that contain at least 10 mol % of a negatively charged lipid coupled to a non-zwitterionic moiety are stable in the blood. Liposomes containing at least 1 mol % of such lipids may be frozen safely.

Claims (8)

1. A composition comprising liposomes that contain at least one biologically active agent

wherein the ordered bilayer(s) of said liposomes consist(s) essentially of:

(a) one or more vesicle forming lipids, which are phospholipids or sphingolipids such that;

(b) at least 1 mol % of said bilayer(s) is phosphatidylglycerol (PG) and/or phosphatidylinositol (PI);

(c) 5-20 mol % cholesterol; and

wherein said liposomes have a mean diameter between 80-200 nm +/−25 nm; and

have a transition temperature (T c ) of at least 38° C.

which composition is cryostable in the absence of cryoprotectant.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVE 2 APPLICATION NUMBERS PREVIOUSLY RECORDED AT REEL: 07234 FRAME: 0137. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Oct 9, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073133/0142 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF 8 PROPERTY NUMBERS PREVIOUSLY RECORDED AT REEL: 072341 FRAME: 0137. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Oct 8, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073058/0985 →
CHANGE OF NAME Recorded Aug 7, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 072341/0137 →
RELEASE OF SECURITY INTEREST Recorded May 5, 2021
From: BANK OF AMERICA, N.A.
To: JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED; CELATOR PHARMACEUTICALS, INC.; CAVION, INC.
Reel/Frame 056150/0708 →
SECURITY AGREEMENT Recorded May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →
SECURITY AGREEMENT Recorded Jul 12, 2016
From: CELATOR PHARMACEUTICALS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 039312/0397 →
RELEASE OF SECURITY INTEREST Recorded Jun 15, 2012
From: THOMAS, MCNERNEY & PARTNERS II, L.P.; TMP NOMINEE II, LLC; TMP ASSOCIATES II, L.P.; DOMAIN PARTNERS VI, L.P.; VENTURES WEST 7 LIMITED PARTNERSHIP; VENTURES WEST 7 U.S. LIMITED PARTNERSHIP; WORKING OPPORTUNITY FUND (EVCC) LTD.; BDC CAPITAL INC.; QUAKER BIOVENTURES, L.P.; GARDEN STATE LIFE SCIENCES VENTURE FUND, L.P.
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 028385/0371 →